The White House laid out measures to tackle high list prices for drugs last week, hitting out at "freeloading" foreign countries that benefit from US pharmaceutical research. The FT's David Crow explains. 

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on News in Focus when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Comments have not been enabled for this podcast.

Follow the topics in this podcast